sparfloxacin has been researched along with Electrocardiogram QT Prolonged in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalli, A; De Ponti, F; Poluzzi, E; Recanatini, M | 1 |
| Aimoto, M; Kawakami, S; Kurimoto, R; Nagasawa, Y; Sakai, K; Takahara, A | 1 |
| Sugiyama, A | 1 |
| Hashimoto, K; Satoh, Y; Sugiyama, A; Takahara, A | 1 |
| Ahluwalia, G | 1 |
| Chiba, K; Hashimoto, K; Sugiyama, A; Takasuna, K; Watanabe, K | 1 |
| Chiba, K; Hashimoto, K; Satoh, Y; Shiina, H; Sugiyama, A | 1 |
| Anderson, ME; Mazur, A; Roden, DM; Yang, T | 1 |
1 review(s) available for sparfloxacin and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
[Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models].
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Antitubercular Agents; Cation Transport Proteins; Cisapride; Disease Models, Animal; Dogs; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Gastrointestinal Agents; Haloperidol; Histamine H1 Antagonists; Long QT Syndrome; Potassium Channels; Potassium Channels, Voltage-Gated; Sulpiride; Terfenadine; Torsades de Pointes | 2003 |
7 other study(ies) available for sparfloxacin and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
Topics: Anti-Arrhythmia Agents; Cation Transport Proteins; Cluster Analysis; Databases, Factual; Ether-A-Go-Go Potassium Channels; Long QT Syndrome; Models, Molecular; Molecular Conformation; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2002 |
Sensitivity of inhalation anesthetics isoflurane and sevoflurane for the drug-induced QT-interval prolongation in guinea pigs.
Topics: Action Potentials; Anesthetics, Inhalation; Animals; Electrocardiography; Fluoroquinolones; Guinea Pigs; Halothane; Isoflurane; Long QT Syndrome; Male; Sevoflurane | 2020 |
Effects of mexiletine on the canine model of sparfloxacin-induced long QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Blood Pressure; Bundle of His; Chromatography, High Pressure Liquid; Disease Models, Animal; Dogs; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Injections, Intravenous; Long QT Syndrome; Mexiletine; Refractory Period, Electrophysiological; Time Factors; Ventricular Function, Left | 2003 |
Torsade de pointes probably induced by sparfloxain.
Topics: Adult; Diagnosis, Differential; Female; Fluoroquinolones; Humans; India; Long QT Syndrome; Torsades de Pointes; Tuberculosis, Pulmonary | 2003 |
Acute hypokalemia may not be an effective way to sensitize the in situ canine heart for sparfloxacin-induced long QT syndrome.
Topics: Animals; Antitubercular Agents; Dogs; Drug Evaluation, Preclinical; Female; Fluoroquinolones; Furosemide; Heart Conduction System; Hypokalemia; Long QT Syndrome; Models, Animal; Time Factors | 2006 |
Proarrhythmic effects of fluoroquinolone antibacterial agents: in vivo effects as physiologic substrate for torsades.
Topics: Action Potentials; Animals; Anti-Infective Agents; Dogs; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Heart; Heart Block; Levofloxacin; Long QT Syndrome; Male; Models, Animal; Ofloxacin; Torsades de Pointes; Ventricular Dysfunction, Right | 2000 |
Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Cation Transport Proteins; DNA-Binding Proteins; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Gatifloxacin; Long QT Syndrome; Mice; Models, Animal; Moxifloxacin; Patch-Clamp Techniques; Piperazines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quinolines; Rabbits; Trans-Activators; Tumor Cells, Cultured | 2001 |